FIP1L1 and Chronic Eosinophilic Leukemia, Not Otherwise Specified: Based on the National Comprehensive Cancer Network (NCCN) guidelines, the recommended imatinib dosage for CEL patients with the FIP1L1-PDGFRa fusion gene is 100- 400mg daily.